×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Macrogenics Inc. (MGNX) NASDAQ

$14.72 (0.24) (-1.60%)

Market Cap: $933.98M

As of 03/28/24 04:00 PM EDT. Market closed.

(MGNX)

Macrogenics Inc. (MGNX)
NASDAQ

$14.72
(0.24) (-1.60%)

Market Cap: $933.98M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

a career at macrogenics could be waiting for you! please click on "careers" ---------------------------->>> to learn more. macrogenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. macrogenics creates both differentiated molecules that are directed to ... read more

a career at macrogenics could be waiting for you! please click on "careers" ---------------------------->>> to learn more. macrogenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. macrogenics creates both differentiated molecules that are directed to novel cancer targets, as well as “bio-betters,” which are drugs designed to improve upon marketed medicines. the combination of macrogenics’ technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. these are exciting times at macrogenics and we hope that you will take the opportunity to learn more about our organization, our pipeline and to view our job opportunities! read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Scott Koenig
Full Time Employees
415
CEO Compensation (Base)
$598,500
CEO Compensation (Total)
$5.21M
URL
Address
9704 Medical Center Dr, Maryland, Rockville, 20850-3343.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Scott Koenig
Full Time Employees
415
CEO Compensation (Base)
$598,500
CEO Compensation (Total)
$5.21M
Address
9704 Medical Center Dr, Maryland, Rockville, 20850-3343.
PRICE CHART FOR MACROGENICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$14.67
Previous Close
$14.96
Days Range
$14.27 - $15.25
52 week range
$4.29 - $21.88
Volume
809,041
Avg. Volume (30 days)
1,897,411
Market Cap
$933.98M
Dividend Yield
-
P/E
(103.11)
Shares Outstanding
62,432,013
Open
$14.67
Previous Close
$14.96
Days Range
$14.27 - $15.25
52 week range
$4.29 - $21.88
Volume
809,041
Avg. Volume (30 days)
1,897,411
Market Cap
$933.98M
Dividend Yield
-
P/E
(103.11)
Shares Outstanding
62,432,013
FINANCIAL STATEMENTS FOR MACROGENICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR MACROGENICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Peters Jeffrey StuartSenior VP and General CounselMar 06, 2024 Option Exercise$10.9019,625213,87528,520Mar 08, 2024, 04:14 PM
Peters Jeffrey StuartSenior VP and General CounselMar 06, 2024 Sale$21.5019,625421,9388,895Mar 08, 2024, 04:14 PM
Risser Eric BlasiusChief Operating OfficerMar 04, 2024 Option Exercise$10.1515,000152,25080,059Mar 06, 2024, 04:20 PM
Risser Eric BlasiusChief Operating OfficerMar 04, 2024 Sale$19.7641,159813,50165,059Mar 06, 2024, 04:20 PM
Spitznagel ThomasSr VP, Technical OpsMar 04, 2024 Option Exercise$11.5010,000115,00018,316Mar 06, 2024, 04:19 PM
Spitznagel ThomasSr VP, Technical OpsMar 04, 2024 Sale$20.0010,000200,0008,316Mar 06, 2024, 04:19 PM
Karrels JamesSVP, CFO and SecretaryMar 04, 2024 Sale$20.5030,000615,000171,452Mar 06, 2024, 04:18 PM
Peters Jeffrey StuartSenior VP and General CounselFeb 26, 2024 Sale$17.2216,124277,6558,895Feb 28, 2024, 04:20 PM
Peters Jeffrey StuartSenior VP and General CounselFeb 22, 2024 Option Exercise$17.1110,126173,25625,019Feb 26, 2024, 04:27 PM
Bonvini EzioSr VP, Research & CSOFeb 22, 2024 Option Exercise$17.119,366160,252100,892Feb 26, 2024, 04:26 PM
Eck Stephen L.Chief Medical OfficerFeb 15, 2024 Option Exercise$17.406,872119,5739,798Feb 20, 2024, 06:41 PM
Peters Jeffrey StuartSenior VP and General CounselFeb 15, 2024 Option Exercise$17.404,44177,2738,895Feb 20, 2024, 06:05 PM
Koenig ScottPresident and CEOFeb 15, 2024 Option Exercise$17.4014,349249,6731,077,628Feb 20, 2024, 06:04 PM
Cilinski LynnVP, Controller and TreasurerFeb 15, 2024 Option Exercise$17.402,37841,3776,213Feb 20, 2024, 06:04 PM
Risser Eric BlasiusChief Operating OfficerFeb 15, 2024 Option Exercise$17.405,879102,29565,059Feb 20, 2024, 06:04 PM
Karrels JamesSVP, CFO and SecretaryFeb 15, 2024 Option Exercise$17.405,32792,690201,452Feb 20, 2024, 06:04 PM
Spitznagel ThomasSr VP, Technical OpsFeb 15, 2024 Option Exercise$17.405,02087,3488,316Feb 20, 2024, 06:03 PM
Bonvini EzioSr VP, Research & CSOFeb 15, 2024 Option Exercise$17.405,871102,15582,133Feb 20, 2024, 06:03 PM
Bonvini EzioSr VP, Research & CSOFeb 07, 2024 Sale$18.003,33460,01271,334Feb 07, 2024, 04:19 PM
Peters Jeffrey StuartSenior VP and General CounselFeb 05, 2024 Option Exercise$11.1176,251847,35576,251Feb 07, 2024, 04:17 PM
Peters Jeffrey StuartSenior VP and General CounselFeb 05, 2024 Sale$16.5076,2511,258,14221,875Feb 07, 2024, 04:17 PM
Bonvini EzioSr VP, Research & CSOFeb 01, 2024 Sale$15.0013,316199,74074,668Feb 02, 2024, 04:21 PM
Bonvini EzioSr VP, Research & CSOJan 19, 2024 Sale$12.0013,316159,79287,984Jan 22, 2024, 04:57 PM
Bonvini EzioSr VP, Research & CSODec 20, 2023 Sale$10.0818,880190,310101,300Dec 21, 2023, 04:12 PM
BIOTECH TARGET N V10% OwnerOct 02, 2023 Buy$4.46150,000669,5859,929,963Oct 04, 2023, 03:31 PM
BIOTECH TARGET N V10% OwnerSep 07, 2023 Buy$5.26200,0001,052,8409,779,963Sep 11, 2023, 03:39 PM
HURWITZ EDWARDDirectorAug 30, 2023 Buy$4.9115,00073,65033,074Sep 01, 2023, 04:06 PM
Peters Jeffrey StuartSenior VP and General CounselMar 10, 2023 Sale$6.035,37232,3930Mar 14, 2023, 04:22 PM
Peters Jeffrey StuartSenior VP and General CounselFeb 22, 2023 Option Exercise$6.553,37822,1265,372Feb 24, 2023, 04:35 PM
Bonvini EzioSr VP, Research & CSOFeb 22, 2023 Option Exercise$6.553,61923,704120,180Feb 24, 2023, 04:34 PM
BIOTECH TARGET N V10% OwnerFeb 14, 2023 Buy$5.07500,0002,532,6009,579,963Feb 16, 2023, 12:37 PM
BIOTECH TARGET N V10% OwnerJan 19, 2023 Buy$5.30150,000794,9259,079,963Jan 23, 2023, 04:21 PM
BIOTECH TARGET N V10% OwnerDec 27, 2022 Buy$5.61200,0001,121,8008,929,963Dec 28, 2022, 11:03 AM
BIOTECH TARGET N V10% OwnerDec 23, 2022 Buy$5.88200,0001,176,8008,729,963Dec 28, 2022, 11:03 AM
BIOTECH TARGET N V10% OwnerNov 22, 2022 Buy$5.96300,0001,788,1808,529,963Nov 25, 2022, 11:37 AM
Risser Eric BlasiusChief Operating OfficerOct 28, 2022 Option Exercise$1.518,50012,83553,468Oct 31, 2022, 04:36 PM
BIOTECH TARGET N V10% OwnerOct 21, 2022 Buy$4.63250,0001,157,1007,979,963Oct 25, 2022, 04:19 PM
BIOTECH TARGET N V10% OwnerOct 24, 2022 Buy$4.36250,0001,090,5008,229,963Oct 25, 2022, 04:19 PM
BIOTECH TARGET N V10% OwnerOct 20, 2022 Buy$4.00285,9771,143,5657,729,963Oct 21, 2022, 03:03 PM
BIOTECH TARGET N V10% OwnerOct 19, 2022 Buy$3.70168,422623,9197,443,986Oct 21, 2022, 03:03 PM
Karrels JamesSVP, CFO and SecretaryJun 15, 2022 Buy$2.4740,00098,800191,776Jun 17, 2022, 04:18 PM
Bonvini EzioSr VP, Research & CSOMay 14, 2022 Option Exercise$4.161,6666,931114,424May 17, 2022, 05:28 PM
Koenig ScottPresident and CEOMay 16, 2022 Option Exercise$1.5153,26580,4301,049,636May 17, 2022, 05:20 PM
Karrels JamesSVP, CFO and SecretaryMar 28, 2022 Option Exercise$1.518,31612,557151,776Mar 28, 2022, 04:56 PM
Risser Eric BlasiusChief Operating OfficerMar 04, 2022 Option Exercise$0.9450047044,968Mar 04, 2022, 05:45 PM
BIOTECH TARGET N V10% OwnerNov 19, 2021 Buy$18.50200,0003,700,3207,275,564Nov 23, 2021, 12:29 PM
Bonvini EzioSr VP, Research & CSONov 16, 2021 Option Exercise$16.002,54040,640111,090Nov 16, 2021, 05:30 PM
BIOTECH TARGET N V10% OwnerSep 29, 2021 Buy$20.47100,0002,047,4607,075,564Sep 30, 2021, 03:09 PM
BIOTECH TARGET N V10% OwnerSep 28, 2021 Buy$20.64100,0002,063,9606,975,564Sep 30, 2021, 03:09 PM
BIOTECH TARGET N V10% OwnerSep 16, 2021 Buy$20.94400,0008,376,8006,675,564Sep 20, 2021, 12:21 PM
BIOTECH TARGET N V10% OwnerSep 17, 2021 Buy$19.93200,0003,986,6806,875,564Sep 20, 2021, 12:21 PM
Spitznagel ThomasSr VP, BPD & ManufacturingJul 16, 2021 Option Exercise$7.515,00037,5505,000Jul 20, 2021, 05:09 PM
Spitznagel ThomasSr VP, BPD & ManufacturingJul 16, 2021 Sale$25.015,000125,0500Jul 20, 2021, 05:09 PM
Bonvini EzioSr VP, Research & CSOJun 24, 2021 Option Exercise$16.7326,076436,337108,550Jun 28, 2021, 08:14 PM
BIOTECH TARGET N V10% OwnerJun 21, 2021 Buy$21.7475,0001,630,1706,275,564Jun 23, 2021, 01:33 PM
BIOTECH TARGET N V10% OwnerJun 15, 2021 Buy$20.5375,0001,539,6156,100,564Jun 17, 2021, 02:54 PM
BIOTECH TARGET N V10% OwnerJun 16, 2021 Buy$21.04100,0002,104,3906,200,564Jun 17, 2021, 02:54 PM
Spitznagel ThomasSr VP, BPD & ManufacturingApr 15, 2021 Option Exercise$7.515,00037,5505,000Apr 19, 2021, 06:37 PM
Spitznagel ThomasSr VP, BPD & ManufacturingApr 15, 2021 Sale$30.915,000154,5500Apr 19, 2021, 06:37 PM
Karrels JamesSVP, CFO and SecretaryMar 22, 2021 Sale$33.0015,000495,000143,460Mar 24, 2021, 05:07 PM
Bonvini EzioSr VP, Research & CSOMar 22, 2021 Sale$32.003,917125,34479,890Mar 24, 2021, 05:04 PM
Peters Jeffrey StuartGeneral CounselMar 08, 2021 Option Exercise$11.5021,749250,11421,749Mar 09, 2021, 07:55 PM
Peters Jeffrey StuartGeneral CounselMar 08, 2021 Sale$26.5021,749576,3490Mar 09, 2021, 07:55 PM
Karrels JamesSVP, CFO and SecretaryJan 28, 2021 Option Exercise$1.416,0008,490158,460Jan 29, 2021, 05:10 PM
Risser Eric BlasiusSr VP & Chief Business OfficerDec 29, 2020 Option Exercise$1.5150075544,968Dec 30, 2020, 04:05 PM
Risser Eric BlasiusSr VP & Chief Business OfficerDec 29, 2020 Sale$24.1050012,05044,468Dec 30, 2020, 04:05 PM
Risser Eric BlasiusSr VP & Chief Business OfficerNov 30, 2020 Option Exercise$1.5150075544,968Dec 01, 2020, 04:15 PM
Risser Eric BlasiusSr VP & Chief Business OfficerNov 30, 2020 Sale$23.3550011,67544,468Dec 01, 2020, 04:15 PM
Risser Eric BlasiusSr VP & Chief Business OfficerOct 28, 2020 Option Exercise$1.511,5002,26545,968Oct 29, 2020, 07:52 PM
Risser Eric BlasiusSr VP & Chief Business OfficerOct 28, 2020 Sale$20.691,50031,03544,468Oct 29, 2020, 07:52 PM
Risser Eric BlasiusSr VP & Chief Business OfficerSep 28, 2020 Option Exercise$1.5150075544,968Sep 29, 2020, 04:44 PM
Risser Eric BlasiusSr VP & Chief Business OfficerSep 28, 2020 Sale$25.3350012,66544,468Sep 29, 2020, 04:44 PM
Bonvini EzioSr VP, Research & CSOSep 18, 2020 Sale$32.0018,339586,84883,807Sep 21, 2020, 04:51 PM
Bonvini EzioSr VP, Research & CSOSep 17, 2020 Sale$29.8844,5121,330,019102,146Sep 21, 2020, 04:51 PM
Galbraith KennethDirectorSep 09, 2020 Option Exercise$17.3820,773361,10313,849Sep 10, 2020, 04:44 PM
Galbraith KennethDirectorSep 09, 2020 Sale$27.1120,773563,1560Sep 10, 2020, 04:44 PM
Risser Eric BlasiusSr VP & Chief Business OfficerAug 26, 2020 Option Exercise$1.5150075544,968Aug 27, 2020, 05:04 PM
Risser Eric BlasiusSr VP & Chief Business OfficerAug 26, 2020 Sale$27.1050013,55044,468Aug 27, 2020, 05:04 PM
Spitznagel ThomasSr VP, BPD & ManufacturingAug 20, 2020 Option Exercise$7.517,50056,3257,500Aug 21, 2020, 04:05 PM
Spitznagel ThomasSr VP, BPD & ManufacturingAug 20, 2020 Sale$26.877,500201,5250Aug 21, 2020, 04:05 PM
Risser Eric BlasiusSr VP & Chief Business OfficerJul 27, 2020 Option Exercise$1.454,4896,50048,468Jul 28, 2020, 05:12 PM
Risser Eric BlasiusSr VP & Chief Business OfficerJul 27, 2020 Sale$25.474,489114,31947,468Jul 28, 2020, 05:12 PM
Peters Jeffrey StuartGeneral CounselJul 02, 2020 Sale$30.002026,0600Jul 06, 2020, 04:25 PM
Risser Eric BlasiusSr VP & Chief Business OfficerJul 02, 2020 Option Exercise$1.513,1004,68147,568Jul 06, 2020, 04:25 PM
Risser Eric BlasiusSr VP & Chief Business OfficerJul 02, 2020 Sale$30.003,10093,00044,468Jul 06, 2020, 04:25 PM
Risser Eric BlasiusSr VP & Chief Business OfficerJun 24, 2020 Option Exercise$0.9450047044,968Jun 25, 2020, 04:57 PM
Risser Eric BlasiusSr VP & Chief Business OfficerJun 24, 2020 Sale$28.4950014,24544,468Jun 25, 2020, 04:57 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMay 26, 2020 Option Exercise$0.9450047044,968May 27, 2020, 04:43 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMay 26, 2020 Sale$26.5950013,29544,468May 27, 2020, 04:43 PM
Spitznagel ThomasSr VP, BPD & ManufacturingMay 20, 2020 Option Exercise$7.517,50056,3257,500May 21, 2020, 07:44 PM
Spitznagel ThomasSr VP, BPD & ManufacturingMay 20, 2020 Sale$25.307,500189,7500May 21, 2020, 07:44 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMay 06, 2020 Option Exercise$1.478,03211,84352,500May 07, 2020, 04:22 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMay 06, 2020 Sale$20.958,032168,30052,000May 07, 2020, 04:22 PM
Risser Eric BlasiusSr VP & Chief Business OfficerApr 16, 2020 Option Exercise$0.946,0005,64044,468Apr 17, 2020, 04:11 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMar 13, 2020 Option Exercise$0.946,0005,64038,468Mar 17, 2020, 04:09 PM
Koenig ScottPresident and CEOMar 11, 2020 Option Exercise$0.94133,163125,173943,103Mar 13, 2020, 04:15 PM
Karrels JamesSVP, CFO and SecretaryMar 06, 2020 Option Exercise$0.944,4734,205152,460Mar 09, 2020, 04:39 PM
Risser Eric BlasiusSr VP & Chief Business OfficerFeb 20, 2020 Option Exercise$0.9450047032,968Feb 21, 2020, 04:44 PM
Risser Eric BlasiusSr VP & Chief Business OfficerFeb 20, 2020 Sale$10.845005,42032,468Feb 21, 2020, 04:44 PM
Risser Eric BlasiusSr VP & Chief Business OfficerFeb 04, 2020 Option Exercise$0.94302832,498Feb 06, 2020, 04:41 PM
Risser Eric BlasiusSr VP & Chief Business OfficerFeb 05, 2020 Option Exercise$0.9462358633,091Feb 06, 2020, 04:41 PM
Risser Eric BlasiusSr VP & Chief Business OfficerFeb 05, 2020 Sale$10.006236,23032,468Feb 06, 2020, 04:41 PM
Risser Eric BlasiusSr VP & Chief Business OfficerFeb 04, 2020 Sale$10.003030032,468Feb 06, 2020, 04:41 PM
Karrels JamesSVP, CFO and SecretaryJan 30, 2020 Option Exercise$0.9412,50011,750147,987Jan 31, 2020, 04:45 PM
Risser Eric BlasiusSr VP & Chief Business OfficerSep 27, 2019 Option Exercise$0.941,6621,56232,468Oct 03, 2019, 04:33 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMay 20, 2019 Option Exercise$0.943,0002,82033,806May 22, 2019, 04:21 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMay 22, 2019 Option Exercise$0.941,00094031,806May 22, 2019, 04:21 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMay 22, 2019 Sale$19.031,00019,02630,806May 22, 2019, 04:21 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMay 20, 2019 Sale$18.383,00055,13130,806May 22, 2019, 04:21 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMar 14, 2019 Option Exercise$0.942,4972,34730,806Mar 18, 2019, 04:36 PM
Fust Matthew KDirectorFeb 06, 2019 Option Exercise$20.156,924139,5197,424Feb 08, 2019, 05:41 PM
Fust Matthew KDirectorFeb 06, 2019 Sale$29.386,924203,427500Feb 08, 2019, 05:41 PM
Peters Jeffrey StuartGeneral CounselFeb 06, 2019 Sale$30.00682,040202Feb 08, 2019, 05:40 PM
Spitznagel ThomasSr VP, BPD & ManufacturingFeb 06, 2019 Option Exercise$7.511,77013,2931,770Feb 08, 2019, 05:40 PM
Spitznagel ThomasSr VP, BPD & ManufacturingFeb 06, 2019 Sale$30.001,77053,1000Feb 08, 2019, 05:40 PM
Risser Eric BlasiusSr VP & Chief Business OfficerJan 28, 2019 Option Exercise$0.946,0005,64028,309Jan 28, 2019, 04:12 PM
Karrels JamesSVP, CFO and SecretaryJan 24, 2019 Option Exercise$0.947,3266,886135,487Jan 28, 2019, 04:10 PM
Karrels JamesSVP, CFO and SecretaryJan 08, 2019 Option Exercise$0.945,3144,995128,161Jan 10, 2019, 03:58 PM
Koenig ScottPresident and CEOJan 03, 2019 Option Exercise$0.9439,89737,503213,060Jan 04, 2019, 04:29 PM
Karrels JamesSVP, CFO and SecretaryDec 18, 2018 Option Exercise$0.945,0004,700122,847Dec 20, 2018, 04:04 PM
Risser Eric BlasiusSr VP & Chief Business OfficerDec 12, 2018 Option Exercise$0.945,0004,70022,309Dec 13, 2018, 04:39 PM
Karrels JamesSVP, CFO and SecretaryNov 27, 2018 Option Exercise$0.943,0002,820117,847Nov 27, 2018, 04:44 PM
Risser Eric BlasiusSr VP & Chief Business OfficerNov 13, 2018 Option Exercise$0.944,0003,76016,100Nov 14, 2018, 04:48 PM
Koenig ScottPresident and CEONov 13, 2018 Option Exercise$0.9440,00037,600173,163Nov 14, 2018, 04:32 PM
Risser Eric BlasiusSr VP & Chief Business OfficerOct 22, 2018 Option Exercise$0.943,0002,82012,100Oct 23, 2018, 12:32 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMar 12, 2018 Option Exercise$0.941,00094010,100Mar 14, 2018, 05:12 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMar 12, 2018 Sale$31.081,00031,0809,100Mar 14, 2018, 05:12 PM
Karrels JamesSVP, CFO and SecretaryMar 05, 2018 Sale$31.005,000155,000114,847Mar 07, 2018, 06:46 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMar 02, 2018 Option Exercise$0.944,0003,76013,100Mar 06, 2018, 05:24 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMar 02, 2018 Sale$30.004,000120,0009,100Mar 06, 2018, 05:24 PM
Risser Eric BlasiusSr VP & Chief Business OfficerFeb 28, 2018 Option Exercise$0.941,00094010,100Mar 01, 2018, 05:24 PM
Risser Eric BlasiusSr VP & Chief Business OfficerFeb 28, 2018 Sale$25.001,00025,0059,100Mar 01, 2018, 05:24 PM
Cilinski LynnVP, Controller and TreasurerFeb 28, 2018 Option Exercise$1.1323,96727,08325,890Mar 01, 2018, 05:24 PM
Cilinski LynnVP, Controller and TreasurerFeb 28, 2018 Sale$25.0123,967599,4361,923Mar 01, 2018, 05:24 PM
Wigginton Jon MarcSr VP, Clinical Dev. & CMOFeb 26, 2018 Option Exercise$23.4611,070259,70218,930Feb 27, 2018, 05:49 PM
Risser Eric BlasiusSr VP & Chief Business OfficerJan 24, 2018 Option Exercise$0.943,0002,82012,100Jan 26, 2018, 04:01 PM
Risser Eric BlasiusSr VP & Chief Business OfficerJan 24, 2018 Sale$22.503,00067,5009,100Jan 26, 2018, 04:01 PM
Risser Eric BlasiusSr VP & Chief Business OfficerJan 24, 2018 Option Exercise$0.943,0002,82012,100Jan 25, 2018, 05:22 PM
Risser Eric BlasiusSr VP & Chief Business OfficerJan 24, 2018 Sale$22.503,00067,5009,100Jan 25, 2018, 05:22 PM
Karrels JamesSVP, CFO and SecretaryJan 16, 2018 Option Exercise$0.946,5166,125119,847Jan 18, 2018, 05:19 PM
Wigginton Jon MarcSr VP, Clinical Dev. & CMOJan 17, 2018 Option Exercise$4.702,52411,86332,524Jan 18, 2018, 05:19 PM
Wigginton Jon MarcSr VP, Clinical Dev. & CMOJan 16, 2018 Option Exercise$4.702,47611,63732,476Jan 18, 2018, 05:19 PM
Wigginton Jon MarcSr VP, Clinical Dev. & CMOJan 17, 2018 Sale$20.002,52450,48030,000Jan 18, 2018, 05:19 PM
Wigginton Jon MarcSr VP, Clinical Dev. & CMOJan 16, 2018 Sale$20.002,47649,52030,000Jan 18, 2018, 05:19 PM
Risser Eric BlasiusSr VP & Chief Business OfficerJan 17, 2018 Option Exercise$0.942,0001,8809,100Jan 18, 2018, 05:19 PM
Karrels JamesSVP, CFO and SecretaryDec 29, 2017 Option Exercise$0.943,0002,820113,331Jan 03, 2018, 12:00 AM
Wigginton Jon MarcSr VP, Clinical Dev. & CMONov 21, 2017 Option Exercise$4.705,00023,50035,000Nov 21, 2017, 05:15 PM
Wigginton Jon MarcSr VP, Clinical Dev. & CMONov 21, 2017 Sale$20.005,000100,00030,000Nov 21, 2017, 05:15 PM
Wigginton Jon MarcSr VP, Clinical Dev. & CMOOct 25, 2017 Option Exercise$4.7010,00047,00040,000Oct 26, 2017, 09:37 AM
Wigginton Jon MarcSr VP, Clinical Dev. & CMOOct 25, 2017 Sale$20.0010,000200,00030,000Oct 26, 2017, 09:37 AM
Karrels JamesSVP, CFO and SecretarySep 05, 2017 Option Exercise$0.945,0004,700110,331Sep 07, 2017, 04:54 PM
Risser Eric BlasiusSr VP & Chief Business OfficerSep 05, 2017 Option Exercise$0.942,0001,8806,000Sep 07, 2017, 04:52 PM
Bonvini EzioSr VP, Research & CSOJul 26, 2017 Option Exercise$1.2253,26465,248146,658Jul 27, 2017, 04:47 PM
Wigginton Jon MarcSr VP, Clinical Dev. & CMOJun 05, 2017 Option Exercise$4.705,00023,50035,000Jun 06, 2017, 04:04 PM
Wigginton Jon MarcSr VP, Clinical Dev. & CMOJun 05, 2017 Sale$20.005,000100,00030,000Jun 06, 2017, 04:04 PM
SARAN ATULSVP & General CounselApr 28, 2017 Option Exercise$21.611,86240,23816,986May 02, 2017, 12:58 PM
Wigginton Jon MarcSr VP, Clinical Dev. & CMOApr 19, 2017 Option Exercise$4.7015,00070,50045,000Apr 20, 2017, 04:15 PM
Wigginton Jon MarcSr VP, Clinical Dev. & CMOApr 19, 2017 Sale$20.0015,000300,00030,000Apr 20, 2017, 04:15 PM
Karrels JamesSVP, CFO and SecretaryJan 25, 2017 Option Exercise$0.945,0004,700105,331Jan 26, 2017, 04:36 PM
Koenig ScottPresident and CEOJan 17, 2017 Option Exercise$0.9479,89875,104133,163Jan 19, 2017, 04:40 PM
Bonvini EzioSr VP, Research & CSOOct 19, 2016 Option Exercise$0.945,3495,028100,944Oct 21, 2016, 07:19 PM
Bonvini EzioSr VP, Research & CSOFeb 11, 2016 Option Exercise$0.9411,96211,24495,595Oct 21, 2016, 07:19 PM
Wigginton Jon MarcSr VP, Clinical Dev. & CMOOct 03, 2016 Option Exercise$4.7010,00047,00010,000Oct 19, 2016, 05:20 PM
Wigginton Jon MarcSr VP, Clinical Dev. & CMOOct 03, 2016 Sale$29.3410,000293,4000Oct 19, 2016, 05:20 PM
Wigginton Jon MarcSr VP, Clinical Dev. & CMOOct 03, 2016 Option Exercise$4.7010,00047,00010,000Oct 05, 2016, 04:49 PM
Wigginton Jon MarcSr VP, Clinical Dev. & CMOOct 03, 2016 Sale$29.3410,000293,4000Oct 05, 2016, 04:49 PM
Cilinski LynnVP, Controller and TreasurerOct 03, 2016 Option Exercise$0.946,2315,8578,154Oct 05, 2016, 04:49 PM
Cilinski LynnVP, Controller and TreasurerOct 03, 2016 Sale$29.286,231182,4441,923Oct 05, 2016, 04:49 PM
Wigginton Jon MarcSr VP Clinical Dev & CMOAug 01, 2016 Option Exercise$4.7020,00094,00020,000Aug 03, 2016, 04:51 PM
Wigginton Jon MarcSr VP Clinical Dev & CMOAug 01, 2016 Sale$30.7820,000615,6000Aug 03, 2016, 04:51 PM
Wigginton Jon MarcSr VP Clinical Dev & CMOJul 01, 2016 Option Exercise$4.705,00023,5005,000Jul 06, 2016, 08:44 PM
Wigginton Jon MarcSr VP Clinical Dev & CMOJul 01, 2016 Sale$27.225,000136,1000Jul 06, 2016, 08:44 PM
Cilinski LynnVP, Controller and TreasurerJul 01, 2016 Option Exercise$0.948,9228,38710,845Jul 06, 2016, 08:43 PM
Cilinski LynnVP, Controller and TreasurerJul 01, 2016 Sale$27.228,922242,8571,923Jul 06, 2016, 08:43 PM
SARAN ATULSVP & General CounselApr 28, 2016 Option Exercise$20.841,86238,80418,848Jun 01, 2016, 11:01 AM
Cilinski LynnVP, Controller and TreasurerMay 27, 2016 Option Exercise$0.945,0004,7006,923May 27, 2016, 02:32 PM
Cilinski LynnVP, Controller and TreasurerMay 27, 2016 Sale$25.005,000125,0001,923May 27, 2016, 02:32 PM
Koenig ScottPresident and CEOMay 16, 2016 Option Exercise$0.9434,61932,542167,782May 17, 2016, 11:55 AM
Koenig ScottPresident and CEOMay 11, 2016 Option Exercise$0.9479,89875,104133,163May 13, 2016, 10:25 AM
SARAN ATULSVP & General CounselApr 28, 2016 Option Exercise$20.841,73036,05318,980Apr 29, 2016, 03:38 PM
Costa Paulo FDirectorMar 03, 2016 Buy$17.2010,000172,00059,435Mar 04, 2016, 08:12 AM
Risser Eric BlasiusSVP, Business DevelopmentFeb 08, 2016 Option Exercise$0.942,5002,3504,000Feb 10, 2016, 08:51 PM
Karrels JamesSVP, CFO and SecretaryJan 29, 2016 Option Exercise$0.9410,0009,400100,331Feb 02, 2016, 04:42 PM
Stein Kathryn ESVP, Product Dev. & RegulatoryJan 07, 2016 Option Exercise$0.8652,35044,82595,555Jan 11, 2016, 01:39 PM
Bonvini EzioSenior VP, ResearchJan 07, 2016 Option Exercise$0.9413,31612,51783,633Jan 11, 2016, 01:39 PM
Wigginton Jon MarcSr VP, ClinicalJan 04, 2016 Option Exercise$4.7010,00047,00010,000Jan 06, 2016, 06:51 PM
Wigginton Jon MarcSr VP, ClinicalJan 04, 2016 Sale$29.6410,000296,4000Jan 06, 2016, 06:51 PM
Risser Eric BlasiusSVP, Business DevelopmentDec 23, 2015 Option Exercise$0.941,5001,4101,500Dec 23, 2015, 01:26 PM
Cilinski LynnVP, Controller and TreasurerJul 01, 2015 Option Exercise$0.943,8153,5867,659Nov 24, 2015, 03:32 PM
Cilinski LynnVP, Controller and TreasurerNov 23, 2015 Option Exercise$0.941,1851,1145,029Nov 24, 2015, 03:32 PM
Cilinski LynnVP, Controller and TreasurerNov 23, 2015 Sale$35.006,921242,2353,844Nov 24, 2015, 03:32 PM
Bonvini EzioSenior VP, ResearchNov 16, 2015 Sale$31.443,11797,99870,317Nov 17, 2015, 03:22 PM
Bonvini EzioSenior VP, ResearchOct 15, 2015 Sale$25.216,233157,13473,434Oct 19, 2015, 03:01 PM
Bonvini EzioSenior VP, ResearchOct 13, 2015 Option Exercise$13.1229,042381,03194,188Oct 15, 2015, 02:37 PM
Karrels JamesSVP, CFO and SecretaryOct 07, 2015 Option Exercise$0.946,0005,64010,100Oct 09, 2015, 09:52 AM
Wigginton Jon MarcSr VP, ClinicalOct 01, 2015 Option Exercise$4.705,00023,5005,000Oct 07, 2015, 04:08 PM
Wigginton Jon MarcSr VP, ClinicalOct 01, 2015 Sale$21.115,000105,5500Oct 07, 2015, 04:08 PM
Wigginton Jon MarcSr VP, ClinicalAug 03, 2015 Option Exercise$4.7010,00047,00010,000Oct 07, 2015, 04:07 PM
Wigginton Jon MarcSr VP, ClinicalAug 03, 2015 Sale$37.1510,000371,5000Oct 07, 2015, 04:07 PM
Bonvini EzioSenior VP, ResearchOct 02, 2015 Option Exercise$0.9417,87716,80479,667Oct 06, 2015, 02:19 PM
Wigginton Jon MarcSr VP, ClinicalOct 01, 2015 Option Exercise$4.705,00023,5005,000Oct 02, 2015, 04:22 PM
Wigginton Jon MarcSr VP, ClinicalOct 01, 2015 Sale$21.115,000105,5500Oct 02, 2015, 04:22 PM
Bonvini EzioSenior VP, ResearchSep 18, 2015 Option Exercise$0.947,0006,58061,790Sep 22, 2015, 03:19 PM
Bonvini EzioSenior VP, ResearchSep 16, 2015 Option Exercise$0.944,0003,76054,790Sep 18, 2015, 10:33 AM
Bonvini EzioSenior VP, ResearchAug 27, 2015 Option Exercise$0.945,0004,70050,790Aug 28, 2015, 11:30 AM
Bonvini EzioSenior VP, ResearchAug 26, 2015 Option Exercise$0.945,0004,70045,790Aug 28, 2015, 11:30 AM
Bonvini EzioSenior VP, ResearchAug 10, 2015 Option Exercise$0.9480,00075,20040,790Aug 11, 2015, 08:41 AM
Wigginton Jon MarcSr VP, ClinicalAug 03, 2015 Option Exercise$4.7010,00047,00010,000Aug 03, 2015, 02:47 PM
Wigginton Jon MarcSr VP, ClinicalAug 03, 2015 Sale$37.1510,000371,5000Aug 03, 2015, 02:47 PM
Bonvini EzioSenior VP, ResearchJul 10, 2015 Option Exercise$0.712,4001,70439,190Jul 13, 2015, 03:23 PM
Bonvini EzioSenior VP, ResearchJul 10, 2015 Sale$38.092,40091,41636,790Jul 13, 2015, 03:23 PM
Cilinski LynnVP, Controller and TreasurerJul 01, 2015 Option Exercise$0.945,0004,70010,765Jul 01, 2015, 04:28 PM
Cilinski LynnVP, Controller and TreasurerJul 01, 2015 Sale$37.156,921257,1155,765Jul 01, 2015, 04:28 PM
Wigginton Jon MarcSr VP, ClinicalJul 01, 2015 Option Exercise$4.705,00023,5005,000Jul 01, 2015, 04:28 PM
Wigginton Jon MarcSr VP, ClinicalJul 01, 2015 Sale$37.155,000185,7500Jul 01, 2015, 04:28 PM
Bonvini EzioSenior VP, ResearchJun 30, 2015 Option Exercise$0.716,4974,61343,287Jul 01, 2015, 04:27 PM
Bonvini EzioSenior VP, ResearchJun 30, 2015 Sale$38.076,497247,34136,790Jul 01, 2015, 04:27 PM
Bonvini EzioSenior VP, ResearchJun 24, 2015 Option Exercise$0.716,0974,32942,887Jul 01, 2015, 04:27 PM
Bonvini EzioSenior VP, ResearchJun 24, 2015 Sale$38.086,097232,17436,790Jul 01, 2015, 04:27 PM
Bonvini EzioSenior VP, ResearchJun 23, 2015 Option Exercise$0.7113,0549,26849,844Jul 01, 2015, 04:27 PM
Bonvini EzioSenior VP, ResearchJun 23, 2015 Sale$38.1413,054497,88036,790Jul 01, 2015, 04:27 PM
Bonvini EzioSenior VP, ResearchJun 24, 2015 Sale$38.086,097232,17417,639Jun 25, 2015, 03:39 PM
Bonvini EzioSenior VP, ResearchJun 23, 2015 Sale$38.1413,054497,88023,736Jun 24, 2015, 03:07 PM
Cilinski LynnVP, Controller and TreasurerJun 15, 2015 Option Exercise$0.945,0004,70016,465Jun 16, 2015, 01:28 PM
Cilinski LynnVP, Controller and TreasurerJun 15, 2015 Sale$35.0010,700374,50011,465Jun 16, 2015, 01:28 PM
Bonvini EzioSenior VP, ResearchJun 15, 2015 Option Exercise$0.716,2334,42543,023Jun 16, 2015, 01:28 PM
Bonvini EzioSenior VP, ResearchJun 15, 2015 Sale$34.016,233211,98436,790Jun 16, 2015, 01:28 PM
Bonvini EzioSenior VP, ResearchMay 15, 2015 Option Exercise$0.716,2334,42543,023May 18, 2015, 04:15 PM
Bonvini EzioSenior VP, ResearchMay 15, 2015 Sale$30.246,233188,48636,790May 18, 2015, 04:15 PM
SARAN ATULGeneral CounselApr 28, 2015 Option Exercise$32.0292529,61920,710Apr 29, 2015, 02:32 PM
Bonvini EzioSenior VP, ResearchApr 15, 2015 Option Exercise$0.716,2334,42543,023Apr 16, 2015, 11:12 AM
Bonvini EzioSenior VP, ResearchApr 15, 2015 Sale$33.986,233211,79736,790Apr 16, 2015, 11:12 AM
Wigginton Jon MarcSr VP, ClinicalApr 01, 2014 Option Exercise$4.705,00023,5005,000Apr 03, 2015, 07:57 AM
Wigginton Jon MarcSr VP, ClinicalApr 01, 2015 Sale$30.865,000154,3000Apr 03, 2015, 07:57 AM
Wigginton Jon MarcSr VP, ClinicalFeb 02, 2015 Option Exercise$4.705,00023,5005,000Feb 03, 2015, 02:58 PM
Wigginton Jon MarcSr VP, ClinicalFeb 02, 2015 Sale$31.045,000155,2000Feb 03, 2015, 02:58 PM
Karrels JamesVP, CFO and SecretaryDec 24, 2014 Option Exercise$0.944,1003,8544,100Dec 29, 2014, 08:05 AM
Stein Kathryn ESVP, Product Dev. & RegulatoryDec 22, 2014 Option Exercise$0.0710,94677754,151Dec 23, 2014, 11:55 AM
Stein Kathryn ESVP, Product Dev. & RegulatoryDec 22, 2014 Sale$37.0010,946405,00243,205Dec 23, 2014, 11:55 AM
Risser Eric BlasiusVP, Business DevelopmentDec 22, 2014 Option Exercise$19.5910,000195,9505,000Dec 23, 2014, 11:33 AM
Risser Eric BlasiusVP, Business DevelopmentDec 18, 2014 Option Exercise$0.9410,0009,40010,000Dec 22, 2014, 11:04 AM
Risser Eric BlasiusVP, Business DevelopmentDec 18, 2014 Sale$33.5010,000335,0000Dec 22, 2014, 11:04 AM
Stein Kathryn ESVP, Product Dev. & RegulatoryDec 18, 2014 Option Exercise$0.7110,9467,77254,151Dec 22, 2014, 11:02 AM
Stein Kathryn ESVP, Product Dev. & RegulatoryDec 18, 2014 Sale$33.0010,946361,21843,205Dec 22, 2014, 11:02 AM
Koenig ScottPresident and CEODec 19, 2014 Option Exercise$0.9462,20558,473703,414Dec 22, 2014, 11:02 AM
Risser Eric BlasiusVP, Business DevelopmentNov 24, 2014 Option Exercise$0.9410,0009,40010,000Nov 25, 2014, 02:12 PM
Risser Eric BlasiusVP, Business DevelopmentNov 24, 2014 Sale$27.7510,000277,5000Nov 25, 2014, 02:12 PM
Stein Kathryn ESenior VP, Prd Dev & Reg AffNov 21, 2014 Option Exercise$0.7110,9467,77254,151Nov 24, 2014, 04:34 PM
Stein Kathryn ESenior VP, Prd Dev & Reg AffNov 21, 2014 Sale$27.0010,946295,54243,205Nov 24, 2014, 04:34 PM
Stein Kathryn ESenior VP, Prd Dev & Reg AffNov 17, 2014 Option Exercise$0.942,0901,96545,295Nov 17, 2014, 05:11 PM
Stein Kathryn ESenior VP, Prd Dev & Reg AffNov 14, 2014 Option Exercise$0.9423,21121,81866,416Nov 17, 2014, 05:11 PM
Stein Kathryn ESenior VP, Prd Dev & Reg AffNov 17, 2014 Sale$22.952,09047,96643,205Nov 17, 2014, 05:11 PM
Stein Kathryn ESenior VP, Prd Dev & Reg AffNov 14, 2014 Sale$23.3323,211541,51343,205Nov 17, 2014, 05:11 PM
Bonvini EzioSenior VP, ResearchNov 14, 2014 Option Exercise$0.713,9002,76936,390Nov 17, 2014, 05:11 PM
Risser Eric BlasiusVP, Business DevelopmentNov 13, 2014 Option Exercise$0.9410,0009,40010,000Nov 13, 2014, 02:48 PM
Risser Eric BlasiusVP, Business DevelopmentNov 12, 2014 Option Exercise$0.9410,0009,40015,000Nov 13, 2014, 02:48 PM
Risser Eric BlasiusVP, Business DevelopmentNov 12, 2014 Sale$23.0015,000345,0000Nov 13, 2014, 02:48 PM
Risser Eric BlasiusVP, Business DevelopmentNov 13, 2014 Sale$25.0010,000250,0000Nov 13, 2014, 02:48 PM
SARAN ATULSee remarksOct 28, 2014 Option Exercise$21.7986518,84821,635Oct 30, 2014, 04:51 PM
Bonvini EzioSenior VP, ResearchOct 10, 2014 Option Exercise$0.7140028432,890Oct 15, 2014, 01:38 PM
Bonvini EzioSenior VP, ResearchOct 09, 2014 Option Exercise$0.712,6631,89132,490Oct 10, 2014, 02:54 PM
Bonvini EzioSenior VP, ResearchOct 08, 2014 Option Exercise$0.941,5971,50129,827Oct 10, 2014, 02:54 PM
Wigginton Jon MarcSr V.P., ClinicalOct 01, 2014 Option Exercise$4.705,00023,5005,000Oct 02, 2014, 11:33 AM
Wigginton Jon MarcSr V.P., ClinicalOct 01, 2014 Sale$20.485,000102,4000Oct 02, 2014, 11:33 AM
Risser Eric BlasiusVP, Business DevelopmentSep 02, 2014 Sale$20.898,316173,7215,000Sep 02, 2014, 04:33 PM
Wigginton Jon MarcSenior VP, Clinical Dev.Aug 18, 2014 Option Exercise$4.705,00023,5005,000Aug 19, 2014, 06:43 PM
Wigginton Jon MarcSenior VP, Clinical Dev.Aug 18, 2014 Sale$20.525,000102,6000Aug 19, 2014, 06:43 PM
Risser Eric BlasiusVP, Business DevelopmentJun 30, 2014 Option Exercise$0.948,0007,52021,316Jul 01, 2014, 07:04 PM
Risser Eric BlasiusVP, Business DevelopmentJun 30, 2014 Sale$21.848,000174,72013,316Jul 01, 2014, 07:04 PM
Stein Kathryn ESenior VP, Prd Dev & Reg AffMay 29, 2014 Option Exercise$0.7110,9467,77254,151May 30, 2014, 02:01 PM
Stein Kathryn ESenior VP, Prd Dev & Reg AffMay 29, 2014 Sale$19.7510,946216,18443,205May 30, 2014, 02:01 PM
HURWITZ EDWARDDirectorFeb 18, 2014 Sale$36.50308,51311,260,7251,704,996Feb 18, 2014, 04:16 PM
ORONSKY ARNOLD LDirectorFeb 18, 2014 Sale$36.50200,0007,300,0001,708,716Feb 18, 2014, 04:03 PM
Galbraith KennethDirectorOct 16, 2013 Buy$16.0046,875750,00046,875Oct 18, 2013, 02:36 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Peters Jeffrey StuartSenior VP and General Counsel03/06/2024213,875
Peters Jeffrey StuartSenior VP and General Counsel03/06/2024421,938
Risser Eric BlasiusChief Operating Officer03/04/2024152,250
Risser Eric BlasiusChief Operating Officer03/04/2024813,501
Spitznagel ThomasSr VP, Technical Ops03/04/2024115,000
Spitznagel ThomasSr VP, Technical Ops03/04/2024200,000
Karrels JamesSVP, CFO and Secretary03/04/2024615,000
Peters Jeffrey StuartSenior VP and General Counsel02/26/2024277,655
Peters Jeffrey StuartSenior VP and General Counsel02/22/2024173,256
Bonvini EzioSr VP, Research & CSO02/22/2024160,252
Eck Stephen L.Chief Medical Officer02/15/2024119,573
Peters Jeffrey StuartSenior VP and General Counsel02/15/202477,273
Koenig ScottPresident and CEO02/15/2024249,673
Cilinski LynnVP, Controller and Treasurer02/15/202441,377
Risser Eric BlasiusChief Operating Officer02/15/2024102,295
Karrels JamesSVP, CFO and Secretary02/15/202492,690
Spitznagel ThomasSr VP, Technical Ops02/15/202487,348
Bonvini EzioSr VP, Research & CSO02/15/2024102,155
Bonvini EzioSr VP, Research & CSO02/07/202460,012
Peters Jeffrey StuartSenior VP and General Counsel02/05/2024847,355
Peters Jeffrey StuartSenior VP and General Counsel02/05/20241,258,142
Bonvini EzioSr VP, Research & CSO02/01/2024199,740
Bonvini EzioSr VP, Research & CSO01/19/2024159,792
Bonvini EzioSr VP, Research & CSO12/20/2023190,310
BIOTECH TARGET N V10% Owner10/02/2023669,585
BIOTECH TARGET N V10% Owner09/07/20231,052,840
HURWITZ EDWARDDirector08/30/202373,650
Peters Jeffrey StuartSenior VP and General Counsel03/10/202332,393
Peters Jeffrey StuartSenior VP and General Counsel02/22/202322,126
Bonvini EzioSr VP, Research & CSO02/22/202323,704
BIOTECH TARGET N V10% Owner02/14/20232,532,600
BIOTECH TARGET N V10% Owner01/19/2023794,925
BIOTECH TARGET N V10% Owner12/27/20221,121,800
BIOTECH TARGET N V10% Owner12/23/20221,176,800
BIOTECH TARGET N V10% Owner11/22/20221,788,180
Risser Eric BlasiusChief Operating Officer10/28/202212,835
BIOTECH TARGET N V10% Owner10/21/20221,157,100
BIOTECH TARGET N V10% Owner10/24/20221,090,500
BIOTECH TARGET N V10% Owner10/20/20221,143,565
BIOTECH TARGET N V10% Owner10/19/2022623,919
Karrels JamesSVP, CFO and Secretary06/15/202298,800
Bonvini EzioSr VP, Research & CSO05/14/20226,931
Koenig ScottPresident and CEO05/16/202280,430
Karrels JamesSVP, CFO and Secretary03/28/202212,557
Risser Eric BlasiusChief Operating Officer03/04/2022470
BIOTECH TARGET N V10% Owner11/19/20213,700,320
Bonvini EzioSr VP, Research & CSO11/16/202140,640
BIOTECH TARGET N V10% Owner09/29/20212,047,460
BIOTECH TARGET N V10% Owner09/28/20212,063,960
BIOTECH TARGET N V10% Owner09/16/20218,376,800
BIOTECH TARGET N V10% Owner09/17/20213,986,680
Spitznagel ThomasSr VP, BPD & Manufacturing07/16/202137,550
Spitznagel ThomasSr VP, BPD & Manufacturing07/16/2021125,050
Bonvini EzioSr VP, Research & CSO06/24/2021436,337
BIOTECH TARGET N V10% Owner06/21/20211,630,170
BIOTECH TARGET N V10% Owner06/15/20211,539,615
BIOTECH TARGET N V10% Owner06/16/20212,104,390
Spitznagel ThomasSr VP, BPD & Manufacturing04/15/202137,550
Spitznagel ThomasSr VP, BPD & Manufacturing04/15/2021154,550
Karrels JamesSVP, CFO and Secretary03/22/2021495,000
Bonvini EzioSr VP, Research & CSO03/22/2021125,344
Peters Jeffrey StuartGeneral Counsel03/08/2021250,114
Peters Jeffrey StuartGeneral Counsel03/08/2021576,349
Karrels JamesSVP, CFO and Secretary01/28/20218,490
Risser Eric BlasiusSr VP & Chief Business Officer12/29/2020755
Risser Eric BlasiusSr VP & Chief Business Officer12/29/202012,050
Risser Eric BlasiusSr VP & Chief Business Officer11/30/2020755
Risser Eric BlasiusSr VP & Chief Business Officer11/30/202011,675
Risser Eric BlasiusSr VP & Chief Business Officer10/28/20202,265
Risser Eric BlasiusSr VP & Chief Business Officer10/28/202031,035
Risser Eric BlasiusSr VP & Chief Business Officer09/28/2020755
Risser Eric BlasiusSr VP & Chief Business Officer09/28/202012,665
Bonvini EzioSr VP, Research & CSO09/18/2020586,848
Bonvini EzioSr VP, Research & CSO09/17/20201,330,019
Galbraith KennethDirector09/09/2020361,103
Galbraith KennethDirector09/09/2020563,156
Risser Eric BlasiusSr VP & Chief Business Officer08/26/2020755
Risser Eric BlasiusSr VP & Chief Business Officer08/26/202013,550
Spitznagel ThomasSr VP, BPD & Manufacturing08/20/202056,325
Spitznagel ThomasSr VP, BPD & Manufacturing08/20/2020201,525
Risser Eric BlasiusSr VP & Chief Business Officer07/27/20206,500
Risser Eric BlasiusSr VP & Chief Business Officer07/27/2020114,319
Peters Jeffrey StuartGeneral Counsel07/02/20206,060
Risser Eric BlasiusSr VP & Chief Business Officer07/02/20204,681
Risser Eric BlasiusSr VP & Chief Business Officer07/02/202093,000
Risser Eric BlasiusSr VP & Chief Business Officer06/24/2020470
Risser Eric BlasiusSr VP & Chief Business Officer06/24/202014,245
Risser Eric BlasiusSr VP & Chief Business Officer05/26/2020470
Risser Eric BlasiusSr VP & Chief Business Officer05/26/202013,295
Spitznagel ThomasSr VP, BPD & Manufacturing05/20/202056,325
Spitznagel ThomasSr VP, BPD & Manufacturing05/20/2020189,750
Risser Eric BlasiusSr VP & Chief Business Officer05/06/202011,843
Risser Eric BlasiusSr VP & Chief Business Officer05/06/2020168,300
Risser Eric BlasiusSr VP & Chief Business Officer04/16/20205,640
Risser Eric BlasiusSr VP & Chief Business Officer03/13/20205,640
Koenig ScottPresident and CEO03/11/2020125,173
Karrels JamesSVP, CFO and Secretary03/06/20204,205
Risser Eric BlasiusSr VP & Chief Business Officer02/20/2020470
Risser Eric BlasiusSr VP & Chief Business Officer02/20/20205,420
Risser Eric BlasiusSr VP & Chief Business Officer02/04/202028
Risser Eric BlasiusSr VP & Chief Business Officer02/05/2020586
Risser Eric BlasiusSr VP & Chief Business Officer02/05/20206,230
Risser Eric BlasiusSr VP & Chief Business Officer02/04/2020300
Karrels JamesSVP, CFO and Secretary01/30/202011,750
Risser Eric BlasiusSr VP & Chief Business Officer09/27/20191,562
Risser Eric BlasiusSr VP & Chief Business Officer05/20/20192,820
Risser Eric BlasiusSr VP & Chief Business Officer05/22/2019940
Risser Eric BlasiusSr VP & Chief Business Officer05/22/201919,026
Risser Eric BlasiusSr VP & Chief Business Officer05/20/201955,131
Risser Eric BlasiusSr VP & Chief Business Officer03/14/20192,347
Fust Matthew KDirector02/06/2019139,519
Fust Matthew KDirector02/06/2019203,427
Peters Jeffrey StuartGeneral Counsel02/06/20192,040
Spitznagel ThomasSr VP, BPD & Manufacturing02/06/201913,293
Spitznagel ThomasSr VP, BPD & Manufacturing02/06/201953,100
Risser Eric BlasiusSr VP & Chief Business Officer01/28/20195,640
Karrels JamesSVP, CFO and Secretary01/24/20196,886
Karrels JamesSVP, CFO and Secretary01/08/20194,995
Koenig ScottPresident and CEO01/03/201937,503
Karrels JamesSVP, CFO and Secretary12/18/20184,700
Risser Eric BlasiusSr VP & Chief Business Officer12/12/20184,700
Karrels JamesSVP, CFO and Secretary11/27/20182,820
Risser Eric BlasiusSr VP & Chief Business Officer11/13/20183,760
Koenig ScottPresident and CEO11/13/201837,600
Risser Eric BlasiusSr VP & Chief Business Officer10/22/20182,820
Risser Eric BlasiusSr VP & Chief Business Officer03/12/2018940
Risser Eric BlasiusSr VP & Chief Business Officer03/12/201831,080
Karrels JamesSVP, CFO and Secretary03/05/2018155,000
Risser Eric BlasiusSr VP & Chief Business Officer03/02/20183,760
Risser Eric BlasiusSr VP & Chief Business Officer03/02/2018120,000
Risser Eric BlasiusSr VP & Chief Business Officer02/28/2018940
Risser Eric BlasiusSr VP & Chief Business Officer02/28/201825,005
Cilinski LynnVP, Controller and Treasurer02/28/201827,083
Cilinski LynnVP, Controller and Treasurer02/28/2018599,436
Wigginton Jon MarcSr VP, Clinical Dev. & CMO02/26/2018259,702
Risser Eric BlasiusSr VP & Chief Business Officer01/24/20182,820
Risser Eric BlasiusSr VP & Chief Business Officer01/24/201867,500
Risser Eric BlasiusSr VP & Chief Business Officer01/24/20182,820
Risser Eric BlasiusSr VP & Chief Business Officer01/24/201867,500
Karrels JamesSVP, CFO and Secretary01/16/20186,125
Wigginton Jon MarcSr VP, Clinical Dev. & CMO01/17/201811,863
Wigginton Jon MarcSr VP, Clinical Dev. & CMO01/16/201811,637
Wigginton Jon MarcSr VP, Clinical Dev. & CMO01/17/201850,480
Wigginton Jon MarcSr VP, Clinical Dev. & CMO01/16/201849,520
Risser Eric BlasiusSr VP & Chief Business Officer01/17/20181,880
Karrels JamesSVP, CFO and Secretary12/29/20172,820
Wigginton Jon MarcSr VP, Clinical Dev. & CMO11/21/201723,500
Wigginton Jon MarcSr VP, Clinical Dev. & CMO11/21/2017100,000
Wigginton Jon MarcSr VP, Clinical Dev. & CMO10/25/201747,000
Wigginton Jon MarcSr VP, Clinical Dev. & CMO10/25/2017200,000
Karrels JamesSVP, CFO and Secretary09/05/20174,700
Risser Eric BlasiusSr VP & Chief Business Officer09/05/20171,880
Bonvini EzioSr VP, Research & CSO07/26/201765,248
Wigginton Jon MarcSr VP, Clinical Dev. & CMO06/05/201723,500
Wigginton Jon MarcSr VP, Clinical Dev. & CMO06/05/2017100,000
SARAN ATULSVP & General Counsel04/28/201740,238
Wigginton Jon MarcSr VP, Clinical Dev. & CMO04/19/201770,500
Wigginton Jon MarcSr VP, Clinical Dev. & CMO04/19/2017300,000
Karrels JamesSVP, CFO and Secretary01/25/20174,700
Koenig ScottPresident and CEO01/17/201775,104
Bonvini EzioSr VP, Research & CSO10/19/20165,028
Bonvini EzioSr VP, Research & CSO02/11/201611,244
Wigginton Jon MarcSr VP, Clinical Dev. & CMO10/03/201647,000
Wigginton Jon MarcSr VP, Clinical Dev. & CMO10/03/2016293,400
Wigginton Jon MarcSr VP, Clinical Dev. & CMO10/03/201647,000
Wigginton Jon MarcSr VP, Clinical Dev. & CMO10/03/2016293,400
Cilinski LynnVP, Controller and Treasurer10/03/20165,857
Cilinski LynnVP, Controller and Treasurer10/03/2016182,444
Wigginton Jon MarcSr VP Clinical Dev & CMO08/01/201694,000
Wigginton Jon MarcSr VP Clinical Dev & CMO08/01/2016615,600
Wigginton Jon MarcSr VP Clinical Dev & CMO07/01/201623,500
Wigginton Jon MarcSr VP Clinical Dev & CMO07/01/2016136,100
Cilinski LynnVP, Controller and Treasurer07/01/20168,387
Cilinski LynnVP, Controller and Treasurer07/01/2016242,857
SARAN ATULSVP & General Counsel04/28/201638,804
Cilinski LynnVP, Controller and Treasurer05/27/20164,700
Cilinski LynnVP, Controller and Treasurer05/27/2016125,000
Koenig ScottPresident and CEO05/16/201632,542
Koenig ScottPresident and CEO05/11/201675,104
SARAN ATULSVP & General Counsel04/28/201636,053
Costa Paulo FDirector03/03/2016172,000
Risser Eric BlasiusSVP, Business Development02/08/20162,350
Karrels JamesSVP, CFO and Secretary01/29/20169,400
Stein Kathryn ESVP, Product Dev. & Regulatory01/07/201644,825
Bonvini EzioSenior VP, Research01/07/201612,517
Wigginton Jon MarcSr VP, Clinical01/04/201647,000
Wigginton Jon MarcSr VP, Clinical01/04/2016296,400
Risser Eric BlasiusSVP, Business Development12/23/20151,410
Cilinski LynnVP, Controller and Treasurer07/01/20153,586
Cilinski LynnVP, Controller and Treasurer11/23/20151,114
Cilinski LynnVP, Controller and Treasurer11/23/2015242,235
Bonvini EzioSenior VP, Research11/16/201597,998
Bonvini EzioSenior VP, Research10/15/2015157,134
Bonvini EzioSenior VP, Research10/13/2015381,031
Karrels JamesSVP, CFO and Secretary10/07/20155,640
Wigginton Jon MarcSr VP, Clinical10/01/201523,500
Wigginton Jon MarcSr VP, Clinical10/01/2015105,550
Wigginton Jon MarcSr VP, Clinical08/03/201547,000
Wigginton Jon MarcSr VP, Clinical08/03/2015371,500
Bonvini EzioSenior VP, Research10/02/201516,804
Wigginton Jon MarcSr VP, Clinical10/01/201523,500
Wigginton Jon MarcSr VP, Clinical10/01/2015105,550
Bonvini EzioSenior VP, Research09/18/20156,580
Bonvini EzioSenior VP, Research09/16/20153,760
Bonvini EzioSenior VP, Research08/27/20154,700
Bonvini EzioSenior VP, Research08/26/20154,700
Bonvini EzioSenior VP, Research08/10/201575,200
Wigginton Jon MarcSr VP, Clinical08/03/201547,000
Wigginton Jon MarcSr VP, Clinical08/03/2015371,500
Bonvini EzioSenior VP, Research07/10/20151,704
Bonvini EzioSenior VP, Research07/10/201591,416
Cilinski LynnVP, Controller and Treasurer07/01/20154,700
Cilinski LynnVP, Controller and Treasurer07/01/2015257,115
Wigginton Jon MarcSr VP, Clinical07/01/201523,500
Wigginton Jon MarcSr VP, Clinical07/01/2015185,750
Bonvini EzioSenior VP, Research06/30/20154,613
Bonvini EzioSenior VP, Research06/30/2015247,341
Bonvini EzioSenior VP, Research06/24/20154,329
Bonvini EzioSenior VP, Research06/24/2015232,174
Bonvini EzioSenior VP, Research06/23/20159,268
Bonvini EzioSenior VP, Research06/23/2015497,880
Bonvini EzioSenior VP, Research06/24/2015232,174
Bonvini EzioSenior VP, Research06/23/2015497,880
Cilinski LynnVP, Controller and Treasurer06/15/20154,700
Cilinski LynnVP, Controller and Treasurer06/15/2015374,500
Bonvini EzioSenior VP, Research06/15/20154,425
Bonvini EzioSenior VP, Research06/15/2015211,984
Bonvini EzioSenior VP, Research05/15/20154,425
Bonvini EzioSenior VP, Research05/15/2015188,486
SARAN ATULGeneral Counsel04/28/201529,619
Bonvini EzioSenior VP, Research04/15/20154,425
Bonvini EzioSenior VP, Research04/15/2015211,797
Wigginton Jon MarcSr VP, Clinical04/01/201423,500
Wigginton Jon MarcSr VP, Clinical04/01/2015154,300
Wigginton Jon MarcSr VP, Clinical02/02/201523,500
Wigginton Jon MarcSr VP, Clinical02/02/2015155,200
Karrels JamesVP, CFO and Secretary12/24/20143,854
Stein Kathryn ESVP, Product Dev. & Regulatory12/22/2014777
Stein Kathryn ESVP, Product Dev. & Regulatory12/22/2014405,002
Risser Eric BlasiusVP, Business Development12/22/2014195,950
Risser Eric BlasiusVP, Business Development12/18/20149,400
Risser Eric BlasiusVP, Business Development12/18/2014335,000
Stein Kathryn ESVP, Product Dev. & Regulatory12/18/20147,772
Stein Kathryn ESVP, Product Dev. & Regulatory12/18/2014361,218
Koenig ScottPresident and CEO12/19/201458,473
Risser Eric BlasiusVP, Business Development11/24/20149,400
Risser Eric BlasiusVP, Business Development11/24/2014277,500
Stein Kathryn ESenior VP, Prd Dev & Reg Aff11/21/20147,772
Stein Kathryn ESenior VP, Prd Dev & Reg Aff11/21/2014295,542
Stein Kathryn ESenior VP, Prd Dev & Reg Aff11/17/20141,965
Stein Kathryn ESenior VP, Prd Dev & Reg Aff11/14/201421,818
Stein Kathryn ESenior VP, Prd Dev & Reg Aff11/17/201447,966
Stein Kathryn ESenior VP, Prd Dev & Reg Aff11/14/2014541,513
Bonvini EzioSenior VP, Research11/14/20142,769
Risser Eric BlasiusVP, Business Development11/13/20149,400
Risser Eric BlasiusVP, Business Development11/12/20149,400
Risser Eric BlasiusVP, Business Development11/12/2014345,000
Risser Eric BlasiusVP, Business Development11/13/2014250,000
SARAN ATULSee remarks10/28/201418,848
Bonvini EzioSenior VP, Research10/10/2014284
Bonvini EzioSenior VP, Research10/09/20141,891
Bonvini EzioSenior VP, Research10/08/20141,501
Wigginton Jon MarcSr V.P., Clinical10/01/201423,500
Wigginton Jon MarcSr V.P., Clinical10/01/2014102,400
Risser Eric BlasiusVP, Business Development09/02/2014173,721
Wigginton Jon MarcSenior VP, Clinical Dev.08/18/201423,500
Wigginton Jon MarcSenior VP, Clinical Dev.08/18/2014102,600
Risser Eric BlasiusVP, Business Development06/30/20147,520
Risser Eric BlasiusVP, Business Development06/30/2014174,720
Stein Kathryn ESenior VP, Prd Dev & Reg Aff05/29/20147,772
Stein Kathryn ESenior VP, Prd Dev & Reg Aff05/29/2014216,184
HURWITZ EDWARDDirector02/18/201411,260,725
ORONSKY ARNOLD LDirector02/18/20147,300,000
Galbraith KennethDirector10/16/2013750,000
Load More Insider Transactions
FUNDS WITH A POSITION IN MACROGENICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.6,140,3490.00151%1.73%Other
RA CAPITAL MANAGEMENT, L.P.4,053,0770.61%1085.11%Other
GEODE CAPITAL MANAGEMENT, LLC1,404,0680.00141%6.37%Other
RENAISSANCE TECHNOLOGIES LLC763,5270.01%14.79%Other
AQR CAPITAL MANAGEMENT LLC132,3740.0024%-61.14%Other
TUDOR INVESTMENT CORP ET AL139,0800.0065%ExitedEvent Driven, Other
ALPS ADVISORS INC41,6740.00315%-8.8%Other
BALYASNY ASSET MANAGEMENT L.P.38,9470.0007%246.13%Event Driven
CHANGE IN SHARES OUTSTANDING FOR MACROGENICS INC
STOCK BUYBACKS FOR MACROGENICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
-1.28%
1Q
12/31/2023
06/30/2023
-1.31%
2Q
12/31/2023
03/31/2023
-0.59%
3Q
12/31/2023
12/31/2022
-0.19%
4Q
12/31/2023
09/30/2022
-0.02%
5Q
12/31/2023
06/30/2022
0.10%
6Q
12/31/2023
03/31/2022
0.20%
7Q
12/31/2023
12/31/2021
0.25%
8Q
12/31/2023
09/30/2021
0.45%
9Q
12/31/2023
06/30/2021
2.29%
10Q
12/31/2023
03/31/2021
7.42%
11Q
12/31/2023
12/31/2020
9.26%
12Q
12/31/2023
09/30/2020
12.82%
13Q
12/31/2023
06/30/2020
22.85%
14Q
12/31/2023
03/31/2020
25.37%
15Q
12/31/2023
12/31/2019
25.55%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
-1.28%
1Q
06/30/2023
-1.31%
2Q
03/31/2023
-0.59%
3Q
12/31/2022
-0.19%
4Q
09/30/2022
-0.02%
5Q
06/30/2022
0.10%
6Q
03/31/2022
0.20%
7Q
12/31/2021
0.25%
8Q
09/30/2021
0.45%
9Q
06/30/2021
2.29%
10Q
03/31/2021
7.42%
11Q
12/31/2020
9.26%
12Q
09/30/2020
12.82%
13Q
06/30/2020
22.85%
14Q
03/31/2020
25.37%
15Q
12/31/2019
25.55%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR MACROGENICS INC
LOADING...